← Leaderboards
Andrew S. Pekosz
Washington University
$18,745,795
Attributed
$21,484,153
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,484,153 · 12
By mechanism
N01$7,857,823 · 1
R01$4,057,046 · 4
U54$3,676,246 · 3
U01$2,755,462 · 1
T32$2,309,326 · 1
R21$828,250 · 2
Top collaborators
- Peter C Agre5 shared
- Jay H. Bream5 shared
- Isabelle Coppens5 shared
- George Dimopoulos Dimopoulos5 shared
- Rhoel David Ramos Dinglasan5 shared
- Gregory E Glass5 shared
- Diane E Griffin5 shared
- J. Marie Hardwick5 shared
Most similar at Washington University
Same institution · by research overlap
- Wayne M. Yokoyama$86,270,787
- Kristen Emily Funk$2,423,197
- Chen Shen$1,204,928
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusResponseImmune ResponseInfluenzaVaccinationImmunityInfectionVaccinesProteinsVirus DiseasesBaseMolecularInfluenza EpidemicVirionAntibodiesCellsVirus ReplicationInfluenza Virus VaccineMediatingGenesAntiviral AgentsImmuneAffectSerum
Grant awards (39)
Immunological and Physiological Responses to Measles Vaccine$767,262
R01 · FY2025 · AI · contact PI
Measles virus infection of the respiratory tract$409,375
R01 · FY2024 · AI · contact PI
Virology Resource Core$126,658
U54 · FY2024 · CA · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR)$2,851,444
N01 · FY2023 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA VACCINE RESEARCH ACTIVITIES$2,520,286
N01 · FY2023 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA VACCINE RESEARCH ACTIVITIES$1,681,269
N01 · FY2023 · AI · contact PI
CEIRR: COVID-19 Research Activities$409,738
N01 · FY2023 · AI · contact PI
CEIRR: COVID-19 Research Activities$395,086
N01 · FY2023 · AI · contact PI
Sex differences in immune responses to vaccine and circulating strains of influenza in healthcare workers$1,578,357
U54 · FY2022 · AG · contact PI
Virology Resource Core$211,100
U54 · FY2022 · CA · contact PI
Sex differences in immune responses to vaccine and circulating strains of influenza in healthcare workers$212,411
U54 · FY2021 · AG · contact PI
Virology Resource Core$570,551
U54 · FY2020 · CA · contact PI
Sex differences in immune responses to vaccine and circulating strains of influenza in healthcare workers$308,576
U54 · FY2020 · AG · contact PI
Sex differences in immune responses to vaccine and circulating strains of influenza in healthcare workers$308,577
U54 · FY2019 · AG · contact PI
Sex differences in immune responses to vaccine and circulating strains of influenza in healthcare workers$360,016
U54 · FY2018 · AG · contact PI
Influenza A Virus Infection of Human Nasal Epithelial Cells$405,000
R01 · FY2015 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$424,613
T32 · FY2014 · AI
Influenza A Virus Infection of Human Nasal Epithelial Cells$405,000
R01 · FY2014 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$507,302
T32 · FY2013 · AI
Influenza A Virus Infection of Human Nasal Epithelial Cells$480,699
R01 · FY2013 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$499,422
T32 · FY2012 · AI
Influenza A Virus Infection of Human Nasal Epithelial Cells$405,000
R01 · FY2012 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$450,573
T32 · FY2011 · AI
Training: Molecular & Cellular Bases of Infectious Diseases$427,416
T32 · FY2010 · AI
M2 peptide based vaccines against influenza$538,677
U01 · FY2008 · AI · contact PI
M2 peptide based vaccines against influenza$558,832
U01 · FY2007 · AI · contact PI
Influenza virus assembly and virulence$131,476
R01 · FY2007 · AI · contact PI
Influenza virus assembly and virulence$122,400
R01 · FY2007 · AI · contact PI
M2 peptide based vaccines against influenza$547,067
U01 · FY2006 · AI · contact PI
Influenza virus assembly and virulence$261,459
R01 · FY2006 · AI · contact PI
M2 peptide based vaccines against influenza$552,548
U01 · FY2005 · AI
Cell culture animal models for SARS-CoV$306,000
R21 · FY2005 · AI
Influenza virus assembly and virulence$267,750
R01 · FY2005 · AI
M2 peptide based vaccines against influenza$558,338
U01 · FY2004 · AI
Cell culture animal models for SARS-CoV$292,750
R21 · FY2004 · AI
Influenza virus assembly and virulence$267,750
R01 · FY2004 · AI
Influenza virus assembly and virulence$133,875
R01 · FY2003 · AI
Hantavirus genetics and respiratory cell interactions$114,750
R21 · FY2003 · AI
Hantavirus genetics and respiratory cell interactions$114,750
R21 · FY2002 · AI